Kidney Cancer Trial, Recruiting (NCT07234409)

Kidney Cancer Trial, Recruiting NCT07234409 Sponsor: Niguarda Hospital Condition: Kidney Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07234409 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Kidney Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You have a single kidney tumor on one side only, measuring 7 cm or smaller, confirmed by a CT scan (this is called early-stage kidney cancer, or stage cT1)
There is no sign that the cancer has spread to other parts of the body or nearby lymph nodes
Your doctors have determined that a type of keyhole surgery to remove part of the kidney (using a robotic system called Da Vinci SP) is an appropriate treatment for you
You are willing and able to sign a consent form agreeing to take part in the trial

Who may not be able to join:

You only have one functioning kidney
You have previously had surgery to partially remove the same kidney that is now affected
You have severe, advanced kidney disease (known as chronic kidney disease stage 5) before the operation
You have a condition or medical history that would make one specific surgical approach clearly necessary or much more suitable than others — for example, having had several major abdominal surgeries in the past, having a horseshoe-shaped kidney, or having a stoma (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Paolo Dell'Oglio, MD PhD, ASST Grande Ospedale Metropolitano Niguarda

Phone: +393407981232

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07234409

Sponsor: Niguarda Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Kidney Cancer

Trial contact: +393407981232

More information: https://clinicaltrials.gov/study/NCT07234409

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You have a single kidney tumor on one side only, measuring 7 cm or smaller, confirmed by a CT scan (this is called early-stage kidney cancer, or stage cT1)
There is no sign that the cancer has spread to other parts of the body or nearby lymph nodes
Your doctors have determined that a type of keyhole surgery to remove part of the kidney (using a robotic system called Da Vinci SP) is an appropriate treatment for you
You are willing and able to sign a consent form agreeing to take part in the trial

Who may not be able to join:

You only have one functioning kidney
You have previously had surgery to partially remove the same kidney that is now affected
You have severe, advanced kidney disease (known as chronic kidney disease stage 5) before the operation
You have a condition or medical history that would make one specific surgical approach clearly necessary or much more suitable than others — for example, having had several major abdominal surgeries in the past, having a horseshoe-shaped kidney, or having a stoma (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Niguarda Hospital

Registry

ClinicalTrials.gov

Start date

10 October 2025

Est. completion

31 December 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

TRIFECTA

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov